BSD Medical's Hyperthermia Therapy Now Offered At Cancer Treatment Centers
Cancer Treatment Centers of America in Philadelphia joined BSD's family of customers with the acquisition and installation of a BSD 500 Hyperthermia System to increase their ability to treat advanced and recurrent cancer patients at their facility.
The BSD 500 delivers hyperthermia by elevating the tumor temperature through the use of microwave energy and helps address the limitations of radiotherapy for many patients with advanced stage cancer. When cancer recurrence has followed an initial course of radiation treatment, a second course of radiation may not be viable to the tumor or must be delivered in a much lower, less effective dosage. Hyperthermia increases blood and oxygen circulation within the tumor, thus making a lower dose of radiation more effective.
"We are very excited to be able to offer hyperthermia to our patients as part of our unique, whole person, fully integrated treatment model that provides the best medical technology available," said Lydia Komarnicky, MD, chief of radiology at Cancer Treatment Centers of America in Philadelphia, where the first hyperthermia treatments are now being performed. "We combine these therapies with complementary therapies like nutrition, naturopathy, physical therapy, mind-body medicine and spiritual support to help patients fight their cancer body, mind and spirit."
The BSD 500 provides superficial hyperthermia which is used to non-invasively treat cancerous tumors located within a few centimeters of the surface of the body, such as melanoma and recurrent breast cancer. It is also able to deliver interstitial hyperthermia which is used in treating tumors in the prostate, breast, head and neck and a variety of other tumors.
"We are pleased to welcome Cancer Treatment Centers of America as a new proponent of hyperthermia therapy for cancer," said Hyrum A. Mead, president of BSD Medical Corp. "Cancer Treatment Centers of America is nationally known for treating cancer patients with complex and advanced stage disease. We are excited to be providing the benefits of hyperthermia therapy to their patients."